The FDA normally guards company information, which includes what manufacturing unit a drug is created in, for concern of running afoul of trade secret rules. In 2011, the FDA reported it identified one,900 situations throughout an inspection of a Cetero Analysis facility where by lab specialists that supposedly carried out selected assessments were